Description
Adamax 10 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
Not licensed by the MHRA. Not a medicinal product.
Research-grade synthetic peptide supplied as a 10 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement or medical device. Not for diagnostic or therapeutic use. Must not be administered to people or animals.
Adamax is a catalogue name for an adamantane-modified Semax analogue. Confirm the exact sequence on the lot COA. It is not Semax and not a licensed Semax medicine.
Identification
| Product name | Adamax |
| Research description | Adamantane-modified analogue of Semax (Met-Glu-His-Phe-Pro-Gly-Pro core) |
| Supplier | Opti-Gen Peptides |
| Contents | 10 mg per vial |
| Parent research peptide | Semax (CAS 80714-61-0) |
| Class | Synthetic modified heptapeptide analogue |
| Intended use | Laboratory / in-vitro research only |
Quality / storage
Only the lot COA applies. Store as a laboratory chemical under institutional SOP. No preparation, nasal or injection instructions on this page.
Published research context (not product claims)
Semax (ACTH-fragment analogue) has a larger published set of receptor and CNS-model papers, plus authorised use in some countries. Adamax is discussed mainly as a lipophilic / adamantane-modified derivative intended in research to alter peptide stability or membrane interaction versus Semax. Independent peer-reviewed human evidence specific to Adamax is limited. Do not treat Semax papers as Adamax product claims.
There is no UK marketing authorisation for Adamax.
UK notice
18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.
Reviews
There are no reviews yet.